A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.
Market Scope
Trusted Global Partner of Industry and Medical Professionals for Ophthalmic Market Research, Primary Research, Independent Perspective, & Objective Analysis
Choose Your Experience
Over 500 Clients, Large & Small from Around the World, Trust Market Scope Data & Analysis
Latest Market Reports
Market Scope's industry reports are meticulously prepared by a dedicated team of in-house consultants/analysts with over 100 years of collective experience.
- 269
Comprehensive Pages
- 8
Geographic and Economic Breakouts
- 5
Year Market Forecasts
- 52
Diseases Analyzed
2025 Cornea Products Market Report: Global Analysis for 2024 to 2030, December, 2025
The “2025 Cornea Products Market Report” delivers an in-depth analysis of the global cornea market, highlighting the latest advances in transplantation, crosslinking, and therapeutic devices aimed at restoring and preserving vision. The report estimates disease prevalence across six major corneal conditions and examines evolving treatment approaches, including cornea transplants, therapeutic lenses, phototherapeutic keratectomy (PTK), intrastromal ring segments, and corneal crosslinking.
It also explores the global ecosystem that supports cornea care—spanning organ donation systems, regulatory environments, and the pivotal roles of cornea specialists, eye banks, and nonprofit organizations.
This 2025 edition evaluates more than 70 products from over 50 companies, with forecasts for unit demand and revenue growth through 2030. It features analysis of emerging pipeline technologies yet to generate revenue and profiles 12 leading market participants shaping the future of cornea treatment.
Latest Industry News & Trends
7/21/2026
AIMeetingNewsletterRobotics
WOC 2026 Explores How AI Can Expand Access to Eye Care
Artificial intelligence is quickly evolving from a diagnostic tool into a comprehensive clinical assistant with the potential to expand access to eye care worldwide, as emphasized at the 2026 World...
7/21/2026
ChinaMeetingMyopiaNewsletter
China’s Myopia Prevention Success Could Reshape a Still-Expanding Market
Recent data presented at the 2026 World Ophthalmology Congress demonstrate that China’s myopia reduction efforts are working. Myopia reduction initiatives by Chinese government agencies call for co...
7/21/2026
AIGlaucomaMeetingNewsletter
Octane Analyzes How AI and Practice Workflow are Driving Tech Innovation
The 2026 Octane Ophthalmology Tech Forum focused on how advances in artificial intelligence and physician workflow are influencing the develop-ment and commercialization of new ophthalmic technolog...
7/21/2026
CataractIOLNewsletterPremiumRoboticsSurgical
Robotic Cataract Surgery Can Serve as Catalyst for Premium Growth
Robotic cataract surgery remains a hot topic in ophthalmology, fueled by recent first-in-human procedures and a growing pipeline of robotic platforms. A digitally guided, highly precise surgical sy...
7/21/2026
DealsIOLNewsletter
RxSight to Collaborate with Alcon on PC-IOLs Under New CEO
RxSight has made two significant moves following disappointing sales results in Q2-2026. The Aliso Viejo, California, company announced July 6 that it would collaborate with Alcon to develop adjust...
7/21/2026
CataractNewsletterRefractiveSurgical
LensCrafters Adds Refractive and Cataract Surgery Options to New Center
LensCrafters, part of French company EssilorLuxottica, announced June 30 that it was launching the first LensCrafters Vision & Eye Health Center, adding surgical procedures and advanced diagnostics...
7/21/2026
DiagnosticIOLNewsletterRegulation
Select US FDA Approvals and Clearances in June 2026
The US FDA’s ophthalmic device division granted clearance to three devices using the 510(k) pathway in June 2026, according to the agency’s database. Topcon received clearance for the Harmony Refer...
7/21/2026
NewsletterPresbyopiaRegulationThyroid Eye Disease
PDUFA Dates for Ophthalmic Drug Candidates, July 2026
The US FDA has scheduled the following Prescription Drug User Fee Act (PDUFA) target action dates for ophthalmic drug, drug/device, and biologic candidates.
Provider Surveys & Interviews
Grab a seat at the table and join the thousands of ophthalmologists and optometrists from over 60 countries who are helping shape the next generation of diagnostics, pharmaceuticals, devices, and equipment by sharing your opinion and experience. Make your voice heard!
Choose Your Own Adventure
Participation options include weekly polls, special sponsored surveys, syndicated quarterly surveys, focus groups, and interviews, each with varying levels of honoraria.
Safe, Secure & On Any Device
We follow all industry standards to ensure confidentiality between participants and clients. Start and stop surveys anytime on our free Market Scope+ App or on desktop, each with a personalized dashboard just for you.
Pre-Qualified Invitations
We individually verify all potential participants before each survey or interview, ensuring that only licensed eye care professionals are invited and they are never kicked out or disqualified.
Better Data = Better Decisions
A team of industry experts and analysts review each data point, so you can be confident in the results and trends provided in our reports.
Download the Market Scope+ app to get started!
Market Scope Methodology
A Multi-Step Approach for Accurate & Timely Data
Proprietary data
- 20+ years of physician survey data
- Disease models
- Cultivated database of physicians, ASCs, and hospitals
- Insight from our team of in-house industry experts
Public data
- Attendance and participation at major, worldwide meetings
- Public health systems and registries
- Clinical study data
- Analysis of company-published financial reports
Join Market Scope Today
Register A Corporate Account
Register A Clinical Account
A clinical account gives you access to survey participation and results, weekly polls, benchmark reports, a searchable news archive, and more on a personalized dashboard.